About Spesolimab
Class: | Monoclonal antibody (anti-IL-36 receptor antibody)
Use: | Treatment of generalized pustular psoriasis (GPP) in adults
Adult dose: | Initial dose of 450 mg administered as an intravenous infusion, followed by 450 mg at week 1, then 450 mg every 4 weeks thereafter
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in individuals under 18 years
Side effects: | Injection site reactions, headache, fatigue, nausea, diarrhea, and upper
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.